(MedPage Today)– The centrally acting, extended-release analgesic tapentadol given efficient discomfort relief in patients with knee osteoarthritis, but with less of the gastrointestinal negative effects seen with oxycodone, a stage III research found.
Posts Tagged ‘Oxycodone’
Tapentadol Eases OA Pain (CME/CE)
September 8th, 2010 
Joe Golson 
Posted in Medical News 
Tags: Medpage Today, osteoarthritis, Oxycodone, Phase Iii, phase III study, Tapentadol 
No Comments »
